Logo image of VHAQ

VIVEON HEALTH ACQUISITION CO (VHAQ) Stock Price, Quote, News and Overview

NYSEARCA:VHAQ - NYSE Arca - US92853V1061 - Common Stock - Currency: USD

10.81  -0.34 (-3.05%)

VHAQ Quote, Performance and Key Statistics

VIVEON HEALTH ACQUISITION CO

NYSEARCA:VHAQ (2/21/2024, 8:13:56 PM)

10.81

-0.34 (-3.05%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High12.48
52 Week Low9.92
Market Cap71.89M
Shares6.65M
Float1.64M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO12-23 2020-12-23


VHAQ short term performance overview.The bars show the price performance of VHAQ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -1 -2 -3 -4 -5

VHAQ long term performance overview.The bars show the price performance of VHAQ in the last 1, 2 and 3 years. 1 year 2 years 3 years 2 4 6

The current stock price of VHAQ is 10.81 USD. In the past month the price decreased by -5.18%. In the past year, price increased by 2.37%.

VIVEON HEALTH ACQUISITION CO / VHAQ Daily stock chart

About VHAQ

Company Profile

VHAQ logo image Viveon Health Acquisition Corp. is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company is headquartered in Atlanta, Georgia. The company went IPO on 2020-12-23. The firm is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The firm focuses on businesses that have the primary operations located in North America in the healthcare industry. The firm has no operations and has no revenues.

Company Info

VIVEON HEALTH ACQUISITION CO

3480 Peachtree Road Ne, 2Nd Floor - Suite #112

Atlanta GEORGIA 30092 US

CEO: Jagi Gill

Employees: 0

Phone: 14045797978

VIVEON HEALTH ACQUISITION CO / VHAQ FAQ

What is the stock price of VIVEON HEALTH ACQUISITION CO today?

The current stock price of VHAQ is 10.81 USD. The price decreased by -3.05% in the last trading session.


What is the ticker symbol for VIVEON HEALTH ACQUISITION CO stock?

The exchange symbol of VIVEON HEALTH ACQUISITION CO is VHAQ and it is listed on the NYSE Arca exchange.


On which exchange is VHAQ stock listed?

VHAQ stock is listed on the NYSE Arca exchange.


What is VIVEON HEALTH ACQUISITION CO worth?

VIVEON HEALTH ACQUISITION CO (VHAQ) has a market capitalization of 71.89M USD. This makes VHAQ a Micro Cap stock.


How many employees does VIVEON HEALTH ACQUISITION CO have?

VIVEON HEALTH ACQUISITION CO (VHAQ) currently has 0 employees.


What are the support and resistance levels for VIVEON HEALTH ACQUISITION CO (VHAQ) stock?

VIVEON HEALTH ACQUISITION CO (VHAQ) has a resistance level at 11. Check the full technical report for a detailed analysis of VHAQ support and resistance levels.


Should I buy VIVEON HEALTH ACQUISITION CO (VHAQ) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VIVEON HEALTH ACQUISITION CO (VHAQ) stock pay dividends?

VHAQ does not pay a dividend.


VHAQ Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to VHAQ. When comparing the yearly performance of all stocks, VHAQ is a bad performer in the overall market: 64.43% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

VHAQ Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

VHAQ Ownership and Analysts


Ownership
Inst Owners0.86%
Ins Owners75.66%
Short Float %N/A
Short RatioN/A
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A